How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Syringe and Needle Market
- By Product Type: Disposable Syringes, Reusable Syringes, Safety Syringes, Insulin Syringes, Prefilled Syringes
- By Needle Type: Hypodermic Needles, Spinal Needles, Dental Needles, Intravenous Needles, Pen Needles
- By Material: Plastic Syringes, Glass Syringes, Stainless Steel Needles
- By Application: Hospital Use, Home Healthcare, Diagnostic Laboratories, Veterinary Use, Pharmaceutical Industry
- By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Diagnostic Centers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Disposable Syringes leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 303 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.183 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.191 →
Full report · locked preview
Everything inside the Syringe and Needle Market report
A complete, evidence-based study - 12 chapters and 127 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Needle Type 5
Material 3
Application 5
End User 5
Companies profiled
Becton
Dickinson and Company (BD)
Terumo Corporation
Nipro Corporation
Smiths Medical (a division of ICU Medical)
B. Braun Melsungen AG
Hunan Huacheng Medical Technology Co. Ltd.
Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Ningbo David Medical Device Co. Ltd.
Sungwon Medical Co. Ltd.
Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Nanjing Medical Apparatus Co. Ltd.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Smiths Medical (a division of ICU Medical)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Hunan Huacheng Medical Technology Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Ningbo David Medical Device Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Sungwon Medical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Nanjing Medical Apparatus Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Medtronic plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Gerresheimer AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Fresenius Kabi AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →SteriTech
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,118M by 2033 · 7.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Disposable Syringes32.2
- Reusable Syringes23.4
- Safety Syringes9.3
- Insulin Syringes16.8
- Prefilled Syringes18.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$765.6M → $1,277M · 6.6%
Europe$533.6M → $993.8M · 8.1%
Asia Pacific$487.2M → $863.3M · 7.4%
Latin America$301.6M → $528.1M · 7.3%
Middle East and Africa$232.0M → $423.4M · 7.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.392026
7.402027
7.412028
7.432029
7.432030
7.442031
7.462032
7.462033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Becton29.1
- Dickinson and Company (BD)10.2
- Terumo Corporation6.7
- Nipro Corporation7.8
- Smiths Medical (a division of ICU Medical)10.6
- B. Braun Melsungen AG7.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type22.4%
Needle Type14.7%
Material14.1%
Application21.8%
End User26.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.3
- Europe24.3
- Asia Pacific21.1
- Latin America12.9
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Becton | 82 | 86 | 95 | 98 | 73 | 80 | 86 |
| Dickinson and Company (BD) | 79 | 74 | 81 | 93 | 73 | 73 | 79 |
| Terumo Corporation | 88 | 87 | 65 | 72 | 83 | 84 | 80 |
| Nipro Corporation | 78 | 72 | 80 | 67 | 63 | 63 | 71 |
| Smiths Medical (a division of ICU Medical) | 54 | 73 | 69 | 77 | 67 | 64 | 67 |
| B. Braun Melsungen AG | 68 | 65 | 61 | 56 | 53 | 57 | 60 |
| Hunan Huacheng Medical Technology Co. Ltd. | 44 | 65 | 64 | 52 | 42 | 43 | 52 |
| Jiangsu Yuyue Medical Equipment & Supply Co. Ltd. | 54 | 56 | 52 | 46 | 50 | 49 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Becton
- Dickinson and Company (BD)
- Terumo Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Becton | ◐ | ◐ | ✓ | ✓ | ✓ | ◐ |
| Dickinson and Company (BD) | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Terumo Corporation | ✓ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Nipro Corporation | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Smiths Medical (a division of ICU Medical) | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| B. Braun Melsungen AG | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Hunan Huacheng Medical Technology Co. Ltd. | − | ◐ | − | − | − | − |
| Jiangsu Yuyue Medical Equipment & Supply Co. Ltd. | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Becton86
2Terumo Corporation80
3Dickinson and Company (BD)79
4Nipro Corporation71
5Smiths Medical (a division of ICU Medical)67
6B. Braun Melsungen AG60
7Hunan Huacheng Medical Technology Co. Ltd.52
8Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.51
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
BectonDickinson and Company (BD)Terumo Corporation
Challenger2
Strong scale, closing on the leaders.
Nipro CorporationSmiths Medical (a division of ICU Medical)
Contender1
Focused players with pockets of strength.
B. Braun Melsungen AG
Niche2
Specialists in a single segment or region.
Hunan Huacheng Medical Technology Co. Ltd.Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Syringe and Needle Market — a $421M beachhead inside a $6.58B market.
Beachhead (SOM)$421Mobtainable near-term
Serviceable (SAM)$2.41Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Disposable Syringes
Best fit — highest urgency & budget in Product Type.
Economic buyer76 fit
Reusable Syringes
Strong fit — clear ROI and a fast path to value.
End user67 fit
Safety Syringes
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Needle Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Material
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel30%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Syringe and Needle Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified23%
Evaluation13%
Closed-won5%
$10.9KCAC
$60KLTV
5.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Syringe and Needle Market is a durable-growth opportunity — $6.58B by 2033, compounding at 8.0%.
TAM · 2025$3.55Btoday
TAM · 2033$6.58Bforecast
CAGR8.0%2027–2033
Cumulative$44.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.58BTotal addressable market
SAM$2.52BServiceable available market
SOM$476MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.0% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.58BLarge & growingTAM by 2033 at 8.0% CAGR
$2.52BServiceable nowreachable with today’s model
$476MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.13BBear5.2% CAGR
$6.58BBase8.0% CAGR
$8.42BBull10.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Needle Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Syringe and Needle Market — a $7.70B market by 2033. Plan: grow share from 9.7% to 16.4%.
Market size · 2033$7.70Btotal addressable
Market CAGR4.1%2027–2033
Target share16.4%from 9.7% today
Revenue ambition$1.26Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.7% | 16.4% | Behind |
| Revenue | $681M | $1.26B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 33.7% | 45.2% | On track |
| Customer retention | 86.6% | 93.9% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Needle Type capability
A defensible second engine — invest in Needle Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Needle Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $147M capacity & capability investment
- Greenlight bolt-on M&A in Needle Type
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Syringe and Needle Market conversation — a $3.05B market you can size, segment and defend in minutes.
Market size · 2033$3.05Btotal opportunity
Growth4.3%CAGR to 2033
Addressable buyers1,702+accounts in scope
Typical ROI7.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.1×return on cost, year one
< 3 mopayback period
$47K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
BectonDickinson and Company (BD)Terumo CorporationNipro CorporationSmiths Medical (a division of ICU Medical)B. Braun Melsungen AGHunan Huacheng Medical Technology Co. Ltd.Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Syringe and Needle Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Syringe and Needle Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Syringe Adaptor Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportSyphilis Test Kit Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportSyphilis Rotator Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportSyphilis Kits Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportSyphilis Assay Kit Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportSynthetic Vitamin Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportSynthetic Viral Controls Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportSynthetic Vinyl Gloves Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportSynthetic Vascular Prostheses Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportSynthetic Vascular Patch Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportSynthetic Vascular Grafts Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportSynthetic Surgical Sutures Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.